Dr. Maciejewski on Impact of Eltrombopag on Expansion of Clones in Refractory Aplastic Anemia

Jaroslaw P. Maciejewski, MD, PhD
Published: Monday, Feb 01, 2016



Jaroslaw P. Maciejewski, MD, PhD, chair, Department of Translational Hematology and Oncology Research, Cleveland Clinic, discusses the impact of eltrombopag on an expansion of clones with somatic mutations in patients with refractory aplastic anemia.

In a recent study, researchers examined if the use of eltrombopag had an impact on evolution and clonal expansion in select patients with aplastic anemia. This is based off of prior evidence that suggests that eltrombopag has potential to expand mutant clones and increase the rate of disease progression to myelodysplastic syndromes.

Three out of 13 patients revealed the presence of sole clonal mutational events that expanded. During the course of observation, 2 more patients were reported to have had a clonal expansion. In conclusion, cautioned use of eltrombopag may be warranted, Maciejewski adds. Clearer findings can be presented after long-term, retrospective studies.

SELECTED
LANGUAGE


Jaroslaw P. Maciejewski, MD, PhD, chair, Department of Translational Hematology and Oncology Research, Cleveland Clinic, discusses the impact of eltrombopag on an expansion of clones with somatic mutations in patients with refractory aplastic anemia.

In a recent study, researchers examined if the use of eltrombopag had an impact on evolution and clonal expansion in select patients with aplastic anemia. This is based off of prior evidence that suggests that eltrombopag has potential to expand mutant clones and increase the rate of disease progression to myelodysplastic syndromes.

Three out of 13 patients revealed the presence of sole clonal mutational events that expanded. During the course of observation, 2 more patients were reported to have had a clonal expansion. In conclusion, cautioned use of eltrombopag may be warranted, Maciejewski adds. Clearer findings can be presented after long-term, retrospective studies.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x